Fred Alger Management »

Nektar Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2M 92k 56.90
2025-06-30 $1.4M 53k 25.84

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Meta Platforms Inc Class A Equity (META)
Amazon.com Equity (AMZN)
AppLovin Corp. Class A Equity (APP)
Nebius Group N.V. Class A Equity (NBIS)
Apple Equity (AAPL)
Broadcom Equity (AVGO)
Alphabet Inc. Class C Equity (GOOG)
Talen Energy Corp Equity (TLN)
Tesla Equity (TSLA)
Sea Limited Sponsored ADR Class A Equity (SE)
Netflix Equity (NFLX)
Western Digital Corporation Equity (WDC)
Natera Equity (NTRA)

View all positions for Fred Alger Management

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics